btt Corp
btt Corp.

Press releases,
recent media coverage.

Press releases, media coverage, testimonial videos, case reports, and articles

All MediaPress ReleasesTestimonial VideosInside bttArticlesCase Reports

Press Releases

Official announcements, institutional updates, partnerships and scientific developments from btt.

Aug 25, 2026

BTT Medical Institute Launches First-in-Human Safety Clinical Trial Evaluating Induced Hyperthermia with the Computerized Brain-Guided Abreu BTT 700 Temperature Management System (TMS) Inspired by the Nobel Prize-recognized Malarial Fever Therapy

Initial phase study marks the clinical evaluation of the Abreu BTT 700 TMS and its thermofebrile protocol, laying the foundation for future efficacy trials in the treatment of ALS and other neurodegenerative disorders.

Dec 4, 2025

BTT Medical Institute Announces Unprecedented Case of Total Reversal of ALS through Re-engineering of the Nobel Prize-Winning Fever Therapy into a Brain-Guided, Artificial Intelligence-Controlled ThermoFebrile Treatment

First video-documented ALS reversal marks a new era for brain health achieved through noninvasive computerized brain-temperature modulation, confirmed by electrophysiological, molecular, and anatomical evidence.

Contact the media team

Media inquiries, interview requests, and press credentials.

pr@bttcorp.com